Kristen Fortney
CIK 2032751 · View on SEC EDGAR ↗
First SEC filing: Sept. 25, 2024 · Latest: Sept. 25, 2024
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2025 | BIOA | A | 530,000 | — | — | 530,000 Direct | — | Acquired | (price as of 2026-08-24) |
| Sept. 25, 2024 | BIOA | A | 424,827 | — | — | 424,827 Direct | — | Acquired | (price as of 2026-08-24) |
| April 17, 2024 | BIOA | A | 708,044 | — | — | 708,044 Direct | — | Acquired | (price as of 2026-08-24) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 18, 2025 | BIOA | Stock Option (Right to Buy) | Common Stock (530,000) | $4.38 | Feb. 17, 2035 | 530,000 | Acquired |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy) | Common Stock (424,827) | $18.00 | Sept. 24, 2034 | 424,827 | Acquired |
| April 17, 2024 | BIOA | Stock Option (Right to Buy) | Common Stock (708,044) | $8.39 | April 16, 2034 | 708,044 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 25, 2024 | BIOA | Common Stock | 1,210,056 | Direct |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (243,714) | 243,714 | Direct |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (115,650) | 115,650 | Direct |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (115,650) | 115,650 | Direct |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (708,044) | 708,044 | Direct |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (5,955) | 5,955 | Indirect |
| Sept. 25, 2024 | BIOA | Stock Option (Right to Buy)→ Common Stock (49,757) | 49,757 | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
BIOA
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $600,000 | — | — | — | $330,000 | — | $15,200 | $2,886,590 |
| 2024 | $520,994 | — | — | — | $208,398 | — | $15,000 | $12,226,906 |
| 2023 | $493,271 | — | — | — | $246,635 | — | $14,400 | $1,380,475 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.